COGT
Cogent Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$34.67
−0.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 39.44x
- P/S forward
- 69.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 11.30x
- Price / sales
- —
- Price / cash flow
- -19.56x
Enterprise value
- Enterprise value
- $5.5B
- EV / sales
- —
- EV / EBITDA
- -14.84x
- EV / EBIT
- -14.22x
- Market cap
- $6.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026